reference/19334038

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19334038

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	949
issn	1365-2036 0269-2813
issueIdentifier	9
pageRange	943-949
publicationName	Alimentary Pharmacology & Therapeutics
startingPage	943
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0909f9222be86a91cdc5024348efe213
bibliographicCitation	Sterling RK, Salvatori JJ, Luketic VA, Sanyal AJ, Fulcher AS, Stravitz RT, Contos MJ, Mills AS, Shiffman ML. A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis. Aliment Pharmacol Ther. 2004 Nov 01;20(9):943–9. doi: 10.1111/j.1365-2036.2004.02214.x. PMID: 15521841.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_708d486bc89d1478e9392fb794ec835f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8ecea45b60205b60b415c9a517d7c0d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e6c311c5538f5ce4df4ebeba9cc26d46 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67cbd9ec1a8a70e0f1d85a4ed7cc6a93 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9e27fa44752f5642793e29189d767e8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ffe7698259d318a5623e0e803aa00e94 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3b4be12285d806e2313dfd632af0734 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf2f7d086463616d89728fd34395947a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87f5311e1236bfd872c84005821c7c19
date	2004-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1111/j.1365-2036.2004.02214.x https://pubmed.ncbi.nlm.nih.gov/15521841
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1160 https://portal.issn.org/resource/ISSN/0269-2813 https://portal.issn.org/resource/ISSN/1365-2036
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A prospective, randomized‐controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis
discusses	http://id.nlm.nih.gov/mesh/M0011171 http://id.nlm.nih.gov/mesh/M0014304 http://id.nlm.nih.gov/mesh/M0022413 http://id.nlm.nih.gov/mesh/M0004221
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015209Q000188 http://id.nlm.nih.gov/mesh/D009173Q000627 http://id.nlm.nih.gov/mesh/D008099Q000473 http://id.nlm.nih.gov/mesh/D002756Q000627 http://id.nlm.nih.gov/mesh/D007166Q000627 http://id.nlm.nih.gov/mesh/D009173Q000031 http://id.nlm.nih.gov/mesh/D014580Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001706Q000379 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D010865 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D015209Q000473 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011446
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31401 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8349 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281078 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7300 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9676

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129182104 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129182106 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129178479 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128094727

Total number of triples: 58.